About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Myocdtm1Msp
targeted mutation 1, Michael S Parmacek
MGI:3773717
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Myocdtm1Msp/Myocdtm1Msp involves: 129 MGI:5907043
cn2
Myocdtm1Msp/Myocdtm1Msp
H2az2Tg(Wnt1-cre)11Rth/H2az2+
involves: 129/Sv * C57BL/6 * CBA MGI:3797650
cn3
Myocdtm1Msp/Myocdtm1Msp
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
involves: 129/Sv * C57BL/6J * FVB/N MGI:5907042
cn4
Myocdtm1Msp/Myocdtm1Msp
Tg(Pax3-cre)1Joe/0
involves: 129/Sv * C57BL/6 * SJL MGI:3797716
cn5
Myocdtm1Msp/Myocdtm1Msp
Tg(Myh6-cre)2182Mds/0
involves: 129/Sv * FVB/N MGI:5907041


Genotype
MGI:5907043
cn1
Allelic
Composition
Myocdtm1Msp/Myocdtm1Msp
Genetic
Background
involves: 129
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Myocdtm1Msp mutation (0 available); any Myocd mutation (53 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• neonatal primary cardiomyocytes transduced with an adenovirus expressing cre recombinase (Ad-cre) show loss of the loosely arranged myofibrils within 72 hours of Ad-cre infection
• cardiomyocytes infected with Ad-cre show widespread apoptosis

cellular
• cardiomyocytes infected with Ad-cre show widespread apoptosis

muscle
• neonatal primary cardiomyocytes transduced with an adenovirus expressing cre recombinase (Ad-cre) show loss of the loosely arranged myofibrils within 72 hours of Ad-cre infection
• cardiomyocytes infected with Ad-cre show widespread apoptosis




Genotype
MGI:3797650
cn2
Allelic
Composition
Myocdtm1Msp/Myocdtm1Msp
H2az2Tg(Wnt1-cre)11Rth/H2az2+
Genetic
Background
involves: 129/Sv * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
H2az2Tg(Wnt1-cre)11Rth mutation (2 available); any H2az2 mutation (26 available)
Myocdtm1Msp mutation (0 available); any Myocd mutation (53 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• majority of mutants die before P3

cardiovascular system
• the architecture of the neointima and tunica media of the ductus arteriosus is disturbed
• increase in fibronectin and laminin in the ductus arteriosus
• all mutants at P2 exhibit patent ductus arteriosus
• E16.5 mutants exhibit diminished expression of smooth muscle cell contractile proteins in the ductus arteriosus
• however, patterning of the cardiac outflow tract and great arteries is normal
• the smooth muscle cells of the ductus arteriosus are heterogeneous in size with a loss of spindle-like cell morphology
• the smooth muscle cells of the ductus arteriosus have relatively few myofibers and show an increase in synthetic organelles, including the rough ER and Golgi

homeostasis/metabolism
• pups become cyanotic shortly after birth

muscle
• the smooth muscle cells of the ductus arteriosus are heterogeneous in size with a loss of spindle-like cell morphology
• the smooth muscle cells of the ductus arteriosus have relatively few myofibers and show an increase in synthetic organelles, including the rough ER and Golgi

cellular
• all mutants at P2 exhibit patent ductus arteriosus
• E16.5 mutants exhibit diminished expression of smooth muscle cell contractile proteins in the ductus arteriosus
• however, patterning of the cardiac outflow tract and great arteries is normal

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
patent ductus arteriosus DOID:13832 OMIM:607411
J:131288




Genotype
MGI:5907042
cn3
Allelic
Composition
Myocdtm1Msp/Myocdtm1Msp
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Genetic
Background
involves: 129/Sv * C57BL/6J * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
A1cfTg(Myh6-cre/Esr1*)1Jmk mutation (5 available); any A1cf mutation (39 available)
Myocdtm1Msp mutation (0 available); any Myocd mutation (53 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 4 month old mice treated with tamoxifen become lethargic within 3-4 days of tamoxifen exposure and die within 7 days

cardiovascular system
• derangements in cardiomyocyte structure and myofibrillar organization are seen throughout the hearts of tamoxifen-treated adult mice
• myofibrillar striations are absent in tamoxifen-treated hearts
• cardiomyocytes of tamoxifen-treated adult mice exhibit indistinct desmosomes and adherens junctions
• structure of the intercalated disc is disrupted in the hearts of tamoxifen-treated adult mice
• loss of cardiomyocytes in tamoxifen-treated adults
• cardiomyocyte disarray with myocyte loss in hearts of tamoxifen-treated adult mice
• sparse, randomly oriented myofibers are seen throughout the sarcoplasm of hearts of tamoxifen-treated adult mice
• hearts of tamoxifen-treated adult mice are enlarged
• hearts of tamoxifen-treated adult mice show large pericardial effusions
• fibrosis in hearts of tamoxifen-treated adult mice
• 6 days after tamoxifen treatment, adult mice exhibit severe dilated cardiomyopathy involving all 4 chambers
• mean ejection fraction is decreased in tamoxifen-treated adult mice
• widespread cardiomyocyte apoptosis in tamoxifen-treated adult mice

growth/size/body
• hearts of tamoxifen-treated adult mice are enlarged

cellular
• widespread cardiomyocyte apoptosis in tamoxifen-treated adult mice

homeostasis/metabolism
• hearts of tamoxifen-treated adult mice show large pericardial effusions

muscle
• derangements in cardiomyocyte structure and myofibrillar organization are seen throughout the hearts of tamoxifen-treated adult mice
• myofibrillar striations are absent in tamoxifen-treated hearts
• cardiomyocytes of tamoxifen-treated adult mice exhibit indistinct desmosomes and adherens junctions
• structure of the intercalated disc is disrupted in the hearts of tamoxifen-treated adult mice
• loss of cardiomyocytes in tamoxifen-treated adults
• cardiomyocyte disarray with myocyte loss in hearts of tamoxifen-treated adult mice
• sparse, randomly oriented myofibers are seen throughout the sarcoplasm of hearts of tamoxifen-treated adult mice
• 6 days after tamoxifen treatment, adult mice exhibit severe dilated cardiomyopathy involving all 4 chambers
• mean ejection fraction is decreased in tamoxifen-treated adult mice
• widespread cardiomyocyte apoptosis in tamoxifen-treated adult mice
• loss of sarcomeres in the hearts of tamoxifen-treated adult mice

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
dilated cardiomyopathy DOID:12930 OMIM:PS115200
J:154666




Genotype
MGI:3797716
cn4
Allelic
Composition
Myocdtm1Msp/Myocdtm1Msp
Tg(Pax3-cre)1Joe/0
Genetic
Background
involves: 129/Sv * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Myocdtm1Msp mutation (0 available); any Myocd mutation (53 available)
Tg(Pax3-cre)1Joe mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging

cardiovascular system
• all mutants at P2 exhibit patent ductus arteriosus
• E16.5 mutants exhibit diminished expression of smooth muscle cell contractile proteins in the ductus arteriosus
• however, patterning of the cardiac outflow tract and great arteries is normal

cellular
• all mutants at P2 exhibit patent ductus arteriosus
• E16.5 mutants exhibit diminished expression of smooth muscle cell contractile proteins in the ductus arteriosus
• however, patterning of the cardiac outflow tract and great arteries is normal

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
patent ductus arteriosus DOID:13832 OMIM:607411
J:131288




Genotype
MGI:5907041
cn5
Allelic
Composition
Myocdtm1Msp/Myocdtm1Msp
Tg(Myh6-cre)2182Mds/0
Genetic
Background
involves: 129/Sv * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Myocdtm1Msp mutation (0 available); any Myocd mutation (53 available)
Tg(Myh6-cre)2182Mds mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 90% of mice die by 10 months of age and no mice survive beyond 1 year of age
• about 20% of mice die before 3 weeks of age

cardiovascular system
• extensive loss of myofibrillar striations
• intercalated discs of hearts appear abnormal
• serpiginous intercalated discs with indistinct desmosomes and adherens junctions
• hearts show extensive loss of cardiomyocytes
• both the left and right atrium are enlarged in 10 month old mice
• four-chamber enlargement in 10 month old mice
• both the left and right ventricles are enlarged in 10 month old mice
• 11.2% of the left ventricle myocardium shows fibrosis compared to 0.46% in controls
• mice develop lethal dilated cardiomyopathy
• systolic function is depressed
• mean ejection fraction is reduced (24.5% vs 57.8% in controls)
• echocardiography shows enlargement of the left atrium, left ventricle, right atrium, and right ventricle in 10 month old hearts

homeostasis/metabolism
• atrial and ventricular thromboses are seen in 10 month old hearts
• atrial thromboses are seen in 10 month old hearts

muscle
• extensive loss of myofibrillar striations
• intercalated discs of hearts appear abnormal
• serpiginous intercalated discs with indistinct desmosomes and adherens junctions
• hearts show extensive loss of cardiomyocytes
• mice develop lethal dilated cardiomyopathy
• systolic function is depressed
• mean ejection fraction is reduced (24.5% vs 57.8% in controls)
• shortened, hypercontracted sarcomeres in hearts

growth/size/body
• four-chamber enlargement in 10 month old mice

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
dilated cardiomyopathy DOID:12930 OMIM:PS115200
J:154666





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory